Clinical trials: Bilateral Cataracts
Age Related Cataracts, Astigmatism
Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric & PODEYE Toric
The investigational devices are approved intraocular lenses (IOL) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery.
- Trial name
- NCT03803852
- Testing
- Intraocular Lens Implantation
- Where
- Austria
- Volunteers
- 750 people
- Sponsor
- Medical University of Vienna
Age Related Cataracts
Evaluation of Physiological Responses at the Anterior Surface of Two (Hydrophobic Acrylic) Intraocular Lens Models
On the day of surgery, the the eye with astigmatism of at least 0.75dpt receives a Vivinex XY1A , HOYA Surgical Optics GmbH and the second eye to be operated receives an XY1, HOYA Surgical Optics GmbH.
- Trial name
- NCT04230629
- Testing
- Vivinex XY1, Vivinex XY1A
- Volunteers
- 50 people
- Sponsor
- Medical University of Vienna
Cataracts
Acrysof Toric SN60T3corneal Astigmatism Between 0.75 and 1.00 D.
The purpose of this study is to evaluate the visual outcomes and patient satisfaction after implantation of a toric IOL in patients with predicted residual corneal astigmatism between 0.75 and 1.00 D.
- Trial name
- TORILIOL (NCT00542581)
- Testing
- The Acrysof toric SN60T3 IOL
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Medical University of South Carolina
Inflammation Following Ocular Surgery
Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery
This study will assess the bioequivalence of Loteprednol Etabonate and the reference listed drug (RLD)
- Trial name
- NCT03531697
- Testing
- Generic Loteprednol Etabonate, Reference Listed Drug (RLD)
- Where
- Canada
- Volunteers
- 381 people
- Sponsor
- Sandoz
Fuch's Endothelial Dystrophy, Cataracts
Study of the Effect of Aspheric Lenses in Patients With Fuch's Dystrophy
The proposed study will recruit patients with mild to moderate Fuch's dystrophy who need cataract surgery alone. They will be randomly assigned to receive either spheric or aspheric lenses.
- Trial name
- NCT02109276
- Testing
- Spheric Sensar(R) 3-piece IOL, Aspheric Tecnis(R) 3-piece IOL
- Where
- Canada
- Sponsor
- Queen's University
Cataract
Visual Outcomes and Patient Satisfaction After Bilateral Implantation of Non-diffractive EDOF IOL Made of a New Hydrophobic Acrylic Material
The objective is to measure the range of vision and patient reported visual disturbances after bilateral implantation for this unique non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) made from the Clareon…
- Trial name
- NCT05488769
- Testing
- Clareon Vivity extended depth of focus (EDOF) intraocular lens
- Where
- Canada
- Volunteers
- 6 people
- Sponsor
- Thomas Nagy
Cataracts
A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification
Approximately 126 subjects scheduled to undergo cataract surgery by phacoemulsification, will be randomized in an even allocation (1:1:1) to either Acuvail, Xibrom or Nevanac.
- Trial name
- NCT01021761
- Testing
- Ketorolac Tromethamine, Bromfenac, nepafenac
- Volunteers
- 126 people, healthy volunteers welcome
- Sponsor
- Frank A. Bucci, Jr., M.D.
Cataract
Pilot Study: Dynamic Light Scattering Device for Studying Early Changes in Cataract
This study will use a new dynamic light scattering device (DLS), developed jointly by NASA and the NEI, to study pre-senile cataracts (cataracts that develop in patients 55 years old or less).
- Trial name
- NCT00067483
- Where
- 2 sites in United States
- Volunteers
- 15 people
- Sponsor
- National Eye Institute (NEI)